These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 404317)

  • 21. Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.
    Rizzo LV; Cunha-Neto E; Teixeira AR
    Infect Immun; 1989 Sep; 57(9):2640-4. PubMed ID: 2474498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialyzable transfer factor in experimental Chagas' disease: in vitro studies.
    Machado RZ; Laure CJ; De Lucca FL
    Trop Med Parasitol; 1986 Dec; 37(4):399-402. PubMed ID: 3105040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
    Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
    Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.
    Umezawa ES; Nascimento MS; Kesper N; Coura JR; Borges-Pereira J; Junqueira AC; Camargo ME
    J Clin Microbiol; 1996 Sep; 34(9):2143-7. PubMed ID: 8862574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.
    Kierszenbaum F
    Immunology; 1981 Nov; 44(3):641-8. PubMed ID: 6797934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of irradiated Trypanosoma cruzi on the pathogenesis of Chagas' disease in dogs.
    Tomlinson MJ; Chapman WL; Hanson WL; Goven AJ
    Rev Inst Med Trop Sao Paulo; 1980; 22(5):219-30. PubMed ID: 6782642
    [No Abstract]   [Full Text] [Related]  

  • 30. Two modes of idiotypic stimulation of T lymphocytes from patients with Chagas' disease: correlations with clinical forms of infection.
    Gazzinelli RT; Gazzinelli G; Cançado JR; Cardoso JE; Brener Z; Colley DG
    Res Immunol; 1990 Oct; 141(8):757-70. PubMed ID: 2128549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immunity in Chagas' disease patients. Lymphoproliferative response to subcellular fractions of Trypanosoma cruzi.
    De Titto EH; Segura EL; Braun M
    Immunol Lett; 1983 Mar; 6(3):161-7. PubMed ID: 6407983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic experimental Chagas' disease: functional syngeneic T-B-cell cooperation in vitro in the absence of an exogenous stimulus.
    Freire-de-Lima C; Peçanha LM; Dos Reis GA
    Infect Immun; 1996 Jul; 64(7):2861-6. PubMed ID: 8698526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
    Ribeiro BM; Crema E; Rodrigues V
    Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of Trypanosoma cruzi antigen in serum from patients with Chagas' disease.
    Araujo FG; Chiari E; Dias JC
    Lancet; 1981 Jan; 1(8214):246-9. PubMed ID: 6109902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autonomic neuropathy and immunological abnormalities in Chagas' disease.
    Fernandez A; Hontebeyrie M; Said G
    Clin Auton Res; 1992 Dec; 2(6):409-12. PubMed ID: 1290925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi.
    Bottasso OA; Ingledew N; Keni M; Morini J; Pividori JF; Rook GA; Stanford JL
    Lancet; 1994 Dec; 344(8936):1540-1. PubMed ID: 7983955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.
    Albareda MC; Natale MA; Cesar GL; Castro Eiro MD; Alvarez MG; Laucella SA
    Methods Mol Biol; 2019; 1955():339-348. PubMed ID: 30868539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.